Monoamine Oxidase Inhibitor [EPC]

Known as: MAOI, Monoamine Oxidase Inhibitor, Monoamine Oxidase Inhibitor (MAOI) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1963-2016
024619632016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
OBJECTIVE Evidence-based data suggest that MAOI therapy may be effective in up to 50% of patients with treatment-resistant… (More)
Is this relevant?
2004
2004
1. The inhibitory effects of tranylcypromine, a nonselective irreversible inhibitor of monoamine oxidase (MAO), on three… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
BACKGROUND Inositol has been reported to be an effective treatment in depression, and we hypothesized that inositol addition… (More)
Is this relevant?
1998
1998
Antidepressive medication may cause impairment of psychomotor functioning relevant to psychosocial adaptation and fitness to… (More)
Is this relevant?
1995
1995
Treatment-resistant depression is a clinical complication that not infrequently affects a certain number of patients. Within the… (More)
Is this relevant?
1990
1990
In open trials, 20 of 21 patients with major depression who developed insomnia during treatment with monoamine oxidase inhibitors… (More)
Is this relevant?
1988
1988
 
Is this relevant?
1985
1985
Fourteen boys (mean age, 9.2 +/- 1.5 years) with Attention Deficit Disorder (ADD) With Hyperactivity were treated with… (More)
Is this relevant?
1985
1985
Patients with "treatment resistant" depression who do not respond to standard methods or relapse over time have a moral and… (More)
Is this relevant?
1985
1985
Adverse cardiovascular responses to anesthesia during either electroconvulsive therapy (ECT) or elective surgical procedures were… (More)
  • table 1
  • table 2
Is this relevant?